Sunshine Act Final Rule Enacted

Sunshine Act Final Rule Enacted

The final provisions for the The Sunshine Act, which requires pharmaceutical and medical device manufacturers to track and publicly report what they spend on physicians at their meetings, were released February 1. Here’s a rundown of how the rule will affect medical meetings—and why some continuing education providers are breathing a qualified sigh of relief.

The Centers for Medicare and Medicaid Services released the long-awaited final rule on the Sunshine Act provisions of the Affordable Care Act on February 1. Pharmaceutical meeting managers and continuing medical education providers are reacting with a mixture of cautious optimism, relief, and resignation.

The transparency bill, passe

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish